Financial debts 0%Suppliers 17%Taxes and wages 5%Other 79%
2025 accounts filed 31 days after the deadline
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 2,168 companies had the same profile as BIOGEM has now. Each dot stands for 6 companies, two years later.
94.1%
were still trading
3.1%
stopped another way
2.5%
went bankrupt
Micro
10 to 20 years old
solvency 10 to 30%
a small loss
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,168 companies, not a prediction for BIOGEM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0838015860
1 director resigningName hiddenVisible after signing in changes role from manager to director · Hidden nameVisible after signing in resigns · Name after signing inVisible after signing in acts as permanent representative · Gazette deed
Capital increase of €130,000 to €248,600
The capital rose from €118,600 to €248,600, with 1,300 new shares · 650 shares · General meeting of 28-01-2016 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as BIOGEM: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201). They are comparable in size and age: total assets between €170,000 and €422,000, founded between 1992 and 2020.
The company number of BIOGEM is 0838.015.860. The VAT number is the same number with BE in front: BE 0838.015.860.
Where is BIOGEM based?
The registered office is at Bihain 28, 6690 Vielsalm.Company details
What does BIOGEM do?
According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201).
What is the legal form of BIOGEM?
BIOGEM is a private limited company (BV).
When was BIOGEM founded?
BIOGEM was founded on 20-07-2011.
Is BIOGEM still active?
Yes, BIOGEM is an active enterprise in the KBO register.
How many employees does BIOGEM have?
BIOGEM had an average of 2.9 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
Which joint committee does BIOGEM fall under?
In its 2023 annual accounts, BIOGEM states joint committee 145 (Horticulture).
What is the turnover of BIOGEM?
The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €88,985 and 2,981 comparable companies of the same size. It probably lies between €170,000 and €460,000. It is a rough estimate.
Is BIOGEM profitable?
In financial year 2025, BIOGEM made a loss of €16,446.
Where can I find the annual accounts of BIOGEM?
BIOGEM filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BIOGEM due?
BIOGEM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline